Publications by authors named "Barbara Kittner"

Claim this Profile
F
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial.
Gili Kenet, Beatrice Nolan, Bulent Zulfikar, Bulent Antmen, Peter Kampmann, Barbara Kittner

Blood· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic modeling and dosing simulation of avalglucosidase alfa for selecting alternative dosing regimen in pediatric patients with late-onset pompe disease.
Gilles Tiraboschi, David Marchionni, Gilles Tuffal, David Fabre, Jean-Marie Martinez, Barbara Kittner

J Pharmacokinet Pharmacodyn· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of avalglucosidase alfa in individuals with infantile-onset Pompe disease enrolled in the phase 2, open-label Mini-COMET study: The 6-month primary analysis report.
Priya S Kishnani, David Kronn, Anaïs Brassier, Alexander Broomfield, James Davison, Barbara Kittner

Genet Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety and tolerability of an oral suspension of fexofenadine for children with allergic rhinitis.
Nathan Segall, Robert E Grubbe, Arden L Levy, Michael J Maloney, Anjuli S Nayak, Barbara Kittner

Allergy Asthma Proc· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.
Frank C Hampel, Barbara Kittner, Julius H van Bavel

Ann Allergy Asthma Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of fexofenadine for the treatment of allergic rhinitis in children 2 to 5 years old.
Henry Milgrom, Barbara Kittner, Robert Lanier, Frank C Hampel

Ann Allergy Asthma Immunol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults.
Danny R Howard, Rajiv Haribhakti, Barbara Kittner, Praful Agrawala

Curr Med Res Opin· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride.
Rajesh Krishna, Sriram Krishnaswami, Barbara Kittner, Abdul J Sankoh, Bradford K Jensen

Biopharm Drug Dispos· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis